{"version":"1.0","type":"link","title":"Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.","author_name":"Tarantino P 외","author_url":"https://prs-insight.online/author/Tarantino%20P","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/81058","thumbnail_width":1200,"thumbnail_height":630}